title: Evaluation of Biosimilars for Formulary Inclusion: Factors for Consideration by P&T Committees.
abstract: P&T committees will play a key role in driving the adoption of biosimilars, which have unique characteristics compared with small-molecule generic drugs. Key elements of formulary review will include clinical parameters, product characteristics, and institutional considerations, which are among the issues covered in this article.
authors.forename: C Lee
authors.initials: CL
authors.lastname: Ventola